Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04243642 · ClinicalTrials.gov registry record
PJ-011726 IntelliSpace Cognition MCI Study
A clinical trial, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Completed
- Registry status
- 117
- Enrollment target
NCT04243642: Completed study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
NCT04243642 is a clinical trial that has completed, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04243642 has completed, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
This study aims to create a reference database of digital cognitive assessment data in combination with neuroimaging data of patients with mild cognitive impairment. The investigators will explore and derive correlations between parameters from routine MRI images and brain volumetric analysis and the digital cognitive data to identify parameters that are relevant to classify MCI patients vs preexisting healthy control data.
Primary Outcome
Create a database of digital cognitive assessment data in combination with neuroimaging data of patients with mild cognitive impairment to: Compare performance of patients with Mild Cognitive Impairment (MCI) to normative data of the healthy US population and characterize a MCI cognitive profile.
Interventions
- DEVICE IntelliSpace Cognition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2022-04-14 |
What the finished NCT04243642 record still lists
NCT04243642 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which IntelliSpace Cognition is the first listed.
NCT04243642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04243642 about?
NCT04243642 is a clinical study titled "PJ-011726 IntelliSpace Cognition MCI Study". This study aims to create a reference database of digital cognitive assessment data in combination with neuroimaging data of patients with mild cognitive impairment. The investigators will explore and derive correlations between parameters from routine MRI images and brain volumetric analysis and th...
What is the current status of trial NCT04243642?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2020-01-30. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT04243642?
The interventions under investigation include: IntelliSpace Cognition (DEVICE).
Who is sponsoring clinical trial NCT04243642?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI